GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients

Go back to GeneDx Announces Whole Genome Sequencing (WGS) Product Enhancements to Accelerate Diagnoses for More Patients
(NASDAQ: WGS) Delayed: 56.18 -2.83 (4.8%)
Previous Close $59.01    52 Week High
Open $59.01    52 Week Low
Day High $59.85    P/E N/A 
Day Low $54.82    EPS
Volume 527,908